Analystreport

Ascendis Pharma A/S (NASDAQ: ASND) had its price target lowered by analysts at HC Wainwright from $0.70 to $0.30. They now have a "buy" rating on the stock.

Ascendis Pharma A/S - American Depositary Shares  (ASND) 
Last ascendis pharma a/s - american depositary shares earnings: 11/18 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ascendispharma.com